Uncertain Pretest Probabilities in Diagnostic Reasoning: The Prevalence Threshold as a Tipping Point

Post-test probabilities are reported as precise numbers even though the pretest probabilities they depend on are uncertain and, for an individual patient, unobservable. Clinicians need a way to tell the mathematical question-how strongly is a change in the pretest estimate carried through to the post-test probability-apart from the clinical question of whether the remaining uncertainty is wide enough to alter management.

To show that the prevalence threshold ( ${\varphi }_e$ ) marks the tipping point at which uncertainty expressed in percentage points is passed on unchanged by a positive test result, and to combine that result with exact conversion of pretest ranges and with the clinician's own action threshold.

Conceptual and analytic study, supported by a targeted narrative overview of pretest-probability estimation and of cognitive influences on diagnostic reasoning. We derived how strongly the positive-result screening curve responds to a change in the pretest probability, examined how that result depends on the scale used, distinguished ${\varphi }_e$ from testing and treatment thresholds, and applied the framework to a primary care example.

For a positive likelihood ratio ${\text{LR}}^{+}>1,{\varphi }_e=1∕\left(1+\sqrt{{\text{LR}}^{+}}\right)$ is the single pretest probability at which one percentage point of pretest uncertainty becomes one percentage point of post-test uncertainty. Below ${\varphi }_e$ such changes are magnified; above it they are damped. The tipping point exists only when uncertainty is measured in percentage points, because a positive result multiplies the odds by the same factor at every pretest probability. In a worked primary care example ( ${\text{LR}}^{+}=8$ , the order of magnitude of a positive urinary nitrite), a pretest estimate of 15% gives a post-test probability of 58.5%, and a plausible pretest range of 10%-25% converts exactly to 47.1%-72.7%. That range straddles a 50% action threshold but not a 40% or an 80% one; ${\varphi }_e$ itself settles nothing.

The prevalence threshold is a closed-form description of how uncertainty travels through a positive test result, not a decision rule and not a guarantee of precision. Its useful role is to prompt clinicians to state a pretest range, convert it, and compare the result with the probability at which they would act differently. Vignette and human-factors studies with clinicians are needed before clinical implementation.